Scilex Holding Co Files 8-K with Financials

TL;DR

Scilex Holding Co dropped an 8-K on Oct 8th with financials and stock/warrant info.

AI Summary

On October 8, 2024, Scilex Holding Company filed an 8-K report detailing financial statements and exhibits. The filing includes information related to common stock and warrants, with the company incorporated in Delaware and headquartered in Palo Alto, California.

Why It Matters

This filing provides investors with updated financial information and details on the company's capital structure, which is crucial for evaluating its current financial health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial filing (8-K) that does not appear to contain any immediately alarming or significant new developments.

Key Players & Entities

• Scilex Holding Co (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• Palo Alto, California (location) — Principal executive address
• October 8, 2024 (date) — Date of report

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 per share SCLX The Nasdaq Stock Mar
• $11.50 — mon stock, each at an exercise price of $11.50 per share SCLXW The Nasdaq Stock Ma
• $11.0 million — September 30, 2024 were in the range of $11.0 million to $13.0 million, compared to $10.1 mil
• $13.0 m — 4 were in the range of $11.0 million to $13.0 million, compared to $10.1 million for th
• $10.1 million — 0 million to $13.0 million, compared to $10.1 million for the same period last year, represen
• $12.0 million — September 30, 2024 were in the range of $12.0 million to $14.0 million, compared to $10.1 mil
• $14.0 m — 4 were in the range of $12.0 million to $14.0 million, compared to $10.1 million for th

Filing Documents

• sclx-20241008.htm (8-K) — 44KB
• sclx-ex99_1.htm (EX-99.1) — 27KB
• img191798281_0.jpg (GRAPHIC) — 14KB
• img191798281_1.jpg (GRAPHIC) — 8KB
• img191798281_2.jpg (GRAPHIC) — 11KB
• img191798281_3.jpg (GRAPHIC) — 17KB
• 0000950170-24-113581.txt ( ) — 298KB
• sclx-20241008.xsd (EX-101.SCH) — 52KB
• sclx-20241008_htm.xml (XML) — 6KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. Scilex Holding Company (the "Company") is providing certain preliminary unaudited financial results for the quarter ended September 30, 2024 based on currently available information. The Company's independent auditor has not reviewed or audited these preliminary estimated financial results. The Company's actual results may differ materially from these preliminary financial results, and may be outside the estimated ranges. This preliminary financial data has been prepared by and is the responsibility of the Company. The Company has not fully completed its review of these preliminary financial results for the quarter ended September 30, 2024. The Company estimates that: ZTlido net sales for the quarter ended September 30, 2024 were in the range of $11.0 million to $13.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 9% to 29%. Total product net sales for the quarter ended September 30, 2024 were in the range of $12.0 million to $14.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 19% to 39%. On October 8, 2024, the Company issued a press release that included certain preliminary unaudited financial results for the quarter ended September 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 2.02 by reference. In accordance with General Instructions B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated October 8, 2024. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCILEX HOLDING COMPANY By: /s/ Jaisim Shah Name: Jaisim Shah Date: October 8, 2024 Title: Chief Executive Officer and President 3

View Full Filing

View this 8-K filing on SEC EDGAR